GlassScriptPhysician profile
Jeffrey Wade
NPI 1114967775
$1,552.82
in general payments reported to CMS, 2019-2025
20 companies · $259 in 2025
The $259 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $186 · 2021: $314 · 2022: $168 · 2023: $139 · 2024: $163 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $561.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $560.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $381.02 | 2019-2021 | |
| Providence Medical Technology, INC. | $347.35 | 2019-2025 | |
| Depuy Synthes Sales INC. | $161.04 | 2020-2025 | Healix Knotless Peek, Truespan Orthocord, Dynatape |
| Smith+Nephew, INC. | $117.30 | 2020-2024 | |
| Ethicon US, LLC | $109.98 | 2023-2025 | Surgiflo Hemostatic Matrix, Dermabond Prineo |
| Biocomposites INC | $58.75 | 2023 | Stimulan |
| Convatec INC. | $51.47 | 2019-2021 | |
| Si-Bone, INC. | $38.22 | 2020-2021 | |
| Heraeus Medical, LLC. | $36.41 | 2023-2025 | Palacos |
| Ermi LLC | $31.39 | 2025 | |
| Amgen INC. | $30.64 | 2021-2024 | Krystexxa |
| Boston Scientific Corporation | $27.67 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Kerecis Limited | $27.45 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Abbvie INC. | $24.69 | 2023 | Dalvance |
| Progenics Pharmaceuticals, INC. | $22.01 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $21.94 | 2019 | |
| Orthofix Medical, INC. | $18.80 | 2024 | Cervical-Stim |
| Misonix INC | $17.50 | 2021 | |
| Zyla Life Sciences, INC. | $14.80 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $14.39 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Wade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.